Abbott Laboratories BDR (ABTT34)

131.28
+1.42(+1.09%)
  • Volume:
    9
  • Bid/Ask:
    128.00/151.00
  • Day's Range:
    131.28 - 131.28

ABTT34 Overview

Prev. Close
129.86
Day's Range
131.28-131.28
Revenue
23.15B
Open
131.28
52 wk Range
128-202.3
EPS
4.83
Volume
9
Market Cap
928.21B
Dividend (Yield)
1.6599
(1.26%)
Average Volume (3m)
2,097
P/E Ratio
22.08
Beta
0.712
1-Year Change
-21.07%
Shares Outstanding
1,751,219,743
Next Earnings Date
-
What is your sentiment on Abbott Laboratories BDR?
or
Market is currently closed. Voting is open during market hours.

Abbott Laboratories BDR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Abbott Laboratories BDR Company Profile

Abbott Laboratories BDR Company Profile

Employees
113000
Market
Brazil
  • Type:Equity
  • Market:Brazil
  • ISIN:BRABTTBDR007

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellNeutral
Technical IndicatorsBuyStrong BuyStrong SellStrong SellStrong Sell
SummaryBuyBuyStrong SellStrong SellSell